Cardiovascular Syst (CSII) 18.36 $CSII FDA Lifts All

New Post Public Reply Private Reply Replies (0) Message Board

Jun 11, 2016 at 9:15 PM

Cardiovascular Syst (CSII) 18.36 $CSII

FDA Lifts All Remaining Shipping Restrictions at Terumo Cardiovascular Systems' Ann Arbor Facility
PR Newswire - Fri Jun 10, 10:30AM CDT
Terumo Cardiovascular Systems (Terumo CVS) received notice from the U.S. Food and Drug Administration (FDA) that it has successfully completed the second and final phase of its work plan to remediate all products manufactured or distributed from Terumo's Ann Arbor, Michigan manufacturing facility, including Terumo® Advanced Perfusion System 1. As a result, all shipping restrictions, imposed as a term of its 2011 consent decree, are now lifted.
CSII: 18.36 (+0.41)

Cardiovascular Systems Has Returned 68.3% Since SmarTrend Recommendation (CSII)
Comtex SmarTrend(R) - Mon Jun 06, 12:46PM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 3 months, Cardiovascular Systems has returned 68.28% as of today's recent price of $17.22.
CSII: 18.36 (+0.41)

Cardiovascular Systems Up 70.3% Since SmarTrend Uptrend Call (CSII)
Comtex SmarTrend(R) - Fri May 27, 12:46PM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 3 months, Cardiovascular Systems has returned 70.28% as of today's recent price of $17.42.
CSII: 18.36 (+0.41)

44.0% Return Seen to Date on SmarTrend Cardiovascular Systems Call (CSII)
Comtex SmarTrend(R) - Fri May 20, 12:34AM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 2 months, Cardiovascular Systems has returned 43.99% as of today's recent price of $14.73.
CSII: 18.36 (+0.41)

Cardiovascular Systems Shares Up 42.4% Since SmarTrend's Buy Recommendation (CSII)
Comtex SmarTrend(R) - Thu May 12, 1:03PM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 2 months, Cardiovascular Systems has returned 42.42% as of today's recent price of $14.57.
CSII: 18.36 (+0.41)

Updated: Harwood Feffer LLP Announces Investigation of Cardiovascular Systems, Inc.
PR Newswire - Thu May 12, 12:07PM CDT
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Cardiovascular Systems, Inc. ("CSII" or the "Company"

(NASDAQ: CSII), concerning whether the board has breached its fiduciary duties to shareholders.
CSII: 18.36 (+0.41)

Cardiovascular (CSII) Narrows Loss in Q3, Revenues Beat
Zacks Equity Research - Zacks Investment Research - Thu May 05, 8:36AM CDT
Cardiovascular Systems Inc. (CSII) reported third-quarter fiscal 2016 adjusted net loss per share of 31 cents.
CAPR: 3.21 (-0.30), CSII: 18.36 (+0.41), BAX: 44.49 (-0.26), CRDC: 2.60 (unch)

Cardiovascular Systems Shares Final Three-Year ORBIT II Results at 2016 Society for Cardiovascular Angiography and Interventions Annual Meeting
BusinessWire - Thu May 05, 7:00AM CDT
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), today shared three-year results from its pivotal ORBIT II study in a featured clinical research presentation at the 2016 Society for Cardiovascular Angiography and Interventions (SCAI) conference in Orlando, Florida.
CSII: 18.36 (+0.41)

Shares of CSII Up 33.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu May 05, 12:54AM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 2 months, Cardiovascular Systems has returned 33.63% as of today's recent price of $13.67.
CSII: 18.36 (+0.41)

Cardiovascular Systems reports 3Q loss
Automated Insights - Wed May 04, 5:06PM CDT
ST. PAUL, Minn. (AP) _ Cardiovascular Systems Inc. (CSII) on Wednesday reported a loss of $22.7 million in its fiscal third quarter.
CSII: 18.36 (+0.41)

Cardiovascular Systems Reports Fiscal 2016 Third-Quarter Financial Results
BusinessWire - Wed May 04, 3:05PM CDT
--Revenues of $44.5 million grew 7% from second quarter of fiscal 2016
CSII: 18.36 (+0.41)

Abaxis (ABAX) Q4 Earnings Beat Estimates; Dividend Raised
Zacks Equity Research - Zacks Investment Research - Fri Apr 29, 9:21AM CDT
Abaxis, Inc. (ABAX) reported fourth-quarter fiscal 2016 earnings per share (EPS) of 36 cents from continuing operations.
BSX: 23.02 (-0.30), CAPR: 3.21 (-0.30), CSII: 18.36 (+0.41), ABAX: 45.53 (-1.36)

NuVasive (NUVA) Tops Q1 Earnings, Grows Internationally
Zacks Equity Research - Zacks Investment Research - Wed Apr 27, 11:03AM CDT
NuVasive, Inc. (NUVA) reported first-quarter 2016 adjusted earnings per share (EPS) of 32 cents.
BSX: 23.02 (-0.30), CSII: 18.36 (+0.41), STJ: 77.35 (-0.72), NUVA: 58.98 (-1.03)

Boston Scientific (BSX) Tops Q1 Earnings, Raises Guidance
Zacks Equity Research - Zacks Investment Research - Wed Apr 27, 10:44AM CDT
Boston Scientific (BSX) announced adjusted earnings per share (EPS) of 28 cents, up 33.3% from the year-ago adjusted number and 16.7% ahead of the Zacks Consensus Estimate.
BSX: 23.02 (-0.30), CSII: 18.36 (+0.41), STJ: 77.35 (-0.72), NUVA: 58.98 (-1.03)

Edwards Lifesciences (EW) Q1 Earnings Top; '16 View Up
Zacks Equity Research - Zacks Investment Research - Wed Apr 27, 9:26AM CDT
Edwards Lifesciences (EW) wrapped up the first quarter on a positive note, with results outshining estimates on both the top and bottom-line front.
BSX: 23.02 (-0.30), CSII: 18.36 (+0.41), EW: 101.52 (-0.96), OFIX: 46.16 (-1.09)

ResMed (RMD) Q3 Earnings Miss, Revenues Meet Estimates
Zacks Equity Research - Zacks Investment Research - Wed Apr 27, 8:04AM CDT
ResMed 9RMD) ended third-quarter fiscal 2016 on a modest note. Nevertheless, ResMed posted positive year-over-year growth as far as its segmental and geographical results are concerned.
BSX: 23.02 (-0.30), CSII: 18.36 (+0.41), RMD: 59.80 (-0.70), OFIX: 46.16 (-1.09)

Can The Uptrend Continue for Cardiovascular Systems (CSII)?
Zacks Equity Research - Zacks Investment Research - Wed Apr 27, 7:03AM CDT
Investors certainly have to be happy with Cardiovascular Systems Inc (CSII) and its short term performance
CSII: 18.36 (+0.41)

Over 70% of Americans Would Buy A Health Tracking Device if Clinically Accurate
ACCESSWIRE - Wed Apr 20, 7:00AM CDT
REDONDO BEACH, CA / ACCESSWIRE / April 20, 2016 / More than eight in ten consumers believe that tracking their own health data with a clinically accurate monitoring device will help improve their overall health, while over 70% of adults would use a personal monitoring device if it were clinically accurate, according to a survey commissioned by Biotricity Inc. (OTCQB: BTCY) and the Society for Participatory Medicine.
FIT: 14.10 (-0.45), CSII: 18.36 (+0.41), MDT: 85.70 (-0.08), BEAT: 16.69 (+0.15), CRY: 11.88 (-0.10), AAPL: 98.83 (-0.82)

Cardiovascular Systems to Webcast Fiscal 2016 Third-Quarter Earnings Conference Call Wednesday, May 4
BusinessWire - Wed Apr 20, 6:00AM CDT
Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII) will host a live webcast of its fiscal 2016 third-quarter conference call on Wednesday, May 4, 2016, at 3:45 p.m. CT (4:45 p.m. ET). Scott Ward, Chairman and Interim President and Chief Executive Officer, and Larry Betterley, Chief Financial Officer, will discuss the company's results for its fiscal third quarter ended March 31, 2016, and its financial outlook. The company will issue a post-market earnings release prior to the call on May 4.
CSII: 18.36 (+0.41)

38.3% Return Seen to Date on SmarTrend Cardiovascular Systems Call (CSII)
Comtex SmarTrend(R) - Tue Apr 19, 12:26AM CDT
SmarTrend identified an Uptrend for Cardiovascular Systems (NASDAQ:CSII) on March 7th, 2016 at $10.23. In approximately 1 month, Cardiovascular Systems has returned 38.32% as of today's recent price of $14.15.
CSII: 18.36 (+0.41)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Yeastar 2026 Summit: AI, Growth, and Global Vision

Reflecting on Two Decades of Innovation Yeastar's 20th anniversary summit in Xiamen was no ordinary gathering. It wasn't just about handshakes and business cards. Nope, it was a celebration intertwined with a deeper vision of growth and influence in the UCaaS space that Yeastar has carved out for itself over the years. Here's a company that's been plotting its course for...

Clarivate's Upcoming Conference Presentation: What to Expect

Conference Time: Will Clarivate Deliver the Goods? Grab your calendars, folks. November 18 is when Clarivate Plc is stepping into the spotlight at the RBC Capital Markets Global Technology, Internet, Media and Telecommunications Conference. Their bigwigs, Matti Shem Tov, the CEO, and Michael Easton, the CFO, will be there to spill the beans. They’re set to take the mike...

Pharmacy Credentials Gain Importance in Delaware Law

Credentialing Takes Front Seat in Pharmacy World Well, hold onto your hats because the pharmacy profession is getting a major upgrade, particularly if you're an investor watching healthcare regulation. The American Association of Colleges of Pharmacy (AACP) has thrown its support behind professional credentialing for pharmacists, which is a big deal, trust me. Pharmacy...

Clarivate's IPOne Revolutionizes AI for IP Pros

A New Dawn for IP Intelligence: Clarivate's Strategic Move Seems like Clarivate's out to shake things up in the IP world. Today, they've announced that their coveted patent and litigation intelligence is now seamlessly integrated with AI workflows on Claude through IPOne. For those not neck-deep in patents and trademarks every day, let’s break it down. This means IP...

Sivers Expands Reach via WT Microelectronics Deal

Breaking Ground with Strategic Collaborations Sivers Semiconductors is flexing its muscles in the semiconductor industry with a new strategic distribution agreement. They announced a partnership with WT Microelectronics, a company that's no rookie in the electronics distribution scene. With WT's global network covering a hefty 43 countries and a clientele of over 25,000,...

Florida's Insurance Premiums: Why They Keep Skyrocketing

What’s Driving Up These Premiums? If you’ve ever felt like your wallet gets lighter every time you pay your insurance premium, welcome to the club. It seems like the cost of insurance in Florida is like a runaway train. But don't just blame the hurricanes. Yeah, they definitely play their part, but there’s a bigger picture lurking behind those price tags. Weather...

Ladera Resort Snags Prestigious Design Honor in 2027

Recognition for a Unique Architectural Gem What's embedded in the heartbeat of Ladera Resort in St. Lucia? A crazy blend of stunning architecture right smack between the Pitons that makes it like nowhere else on Earth. And guess what? Ladera just snagged the Best Design award for 2027 at the Condé Nast Johansens Awards for Excellence. Winning this honor isn’t about...

2026 Shaw Prize: Celebrating Science's Global Impact

Shaw Prize: A Global Stage for Science When it comes to celebrating scientific breakthroughs, the Shaw Prize is the gold standard. On November 10th, 2026, the event unfolded at the iconic Hong Kong Convention and Exhibition Centre, and it was all about honoring those pushing the envelope in science. It’s year 23 for the Shaw Prize, and this ceremony didn’t just hand...

Rain Agent Vaults: Revolutionizing Payments with AI

Innovative Payments with AI Power Alright, folks, Rain's gone and done something that's probably going to shake things up in the payments world—'cause they've given AI agents the ability to handle money like never before. We're not just talking about some run-of-the-mill integration here. This is a genuine game changer, promising to make agents as financially savvy as...

Iconic Brands Falter in New AI-Driven Consumer Landscape

Forget Recognition—It's All About Relevance Now Brand hearts are breaking, folks. That classic suite of household names just took a body blow from the Consequential Brand™ Test. Out of 73, a single champ emerged. Why? Because in the age where AI drives recommendations, it turns out recognizability ain't cutting it. This ain't your granddad’s customer loyalty game...